CompletedPhase 2

Micellar Curcumin and Metabolic Syndrome Biomarkers

Germany42 participantsStarted 2013-07

Plain-language summary

The purpose of this study is to investigate the effect of micellar curcumin on inflammation and lipid metabolism markers in subjects at risk for the metabolic syndrome.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: * Total cholesterol \> 5.2 mmol/L * LDL cholesterol \> 3.4 mmol/L * Triglyceride \> 2.26 mmol/L * CRP \> 2 mg/L Exclusion criteria: * Intake of drugs or dietary supplements * Pregnant women and breastfeeding mothers * Smokers * Previous illnesses such as heart attack, cancer or dementia * Addiction

What they're measuring

C-reactive protein (CRP)

Timeframe: At baseline and 6 weeks

Trial details

NCT IDNCT01925547

SponsorUniversity of Hohenheim

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-03

View on ClinicalTrials.gov More Metabolic Syndrome, Protection Against trials